Page last updated: 2024-10-24

carbamazepine and Dwarfism

carbamazepine has been researched along with Dwarfism in 2 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Dwarfism: A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.

Research Excerpts

ExcerptRelevanceReference
"We report an infant with moyamoya disease and recurrent stroke presenting 10 months after diagnosis (at age 18 months), and discuss the outcome of nonsurgical medical management."1.38Medical management of moyamoya disease and recurrent stroke in an infant with Majewski osteodysplastic primordial dwarfism type II (MOPD II). ( Alanay, Y; Boduroğlu, K; Cetin, M; Haliloğlu, G; Kılıç, E; Oğuz, KK; Unal, S; Utine, E, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mullan, LA1
Mularczyk, EJ1
Kung, LH1
Forouhan, M1
Wragg, JM1
Goodacre, R1
Bateman, JF1
Swanton, E1
Briggs, MD1
Boot-Handford, RP1
Kılıç, E1
Utine, E1
Unal, S1
Haliloğlu, G1
Oğuz, KK1
Cetin, M1
Boduroğlu, K1
Alanay, Y1

Other Studies

2 other studies available for carbamazepine and Dwarfism

ArticleYear
Increased intracellular proteolysis reduces disease severity in an ER stress-associated dwarfism.
    The Journal of clinical investigation, 2017, Oct-02, Volume: 127, Issue:10

    Topics: Activating Transcription Factor 4; Animals; Carbamazepine; Chondrocytes; Collagen Type X; Dwarfism;

2017
Medical management of moyamoya disease and recurrent stroke in an infant with Majewski osteodysplastic primordial dwarfism type II (MOPD II).
    European journal of pediatrics, 2012, Volume: 171, Issue:10

    Topics: Antigens; Carbamazepine; Dwarfism; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight;

2012